We are live on ! Find out more
GDNRU

Gardiner Healthcare Acquisitions Corp. Unit

Delisted

GDNRU was delisted on the 15th of November, 2023.

3 hedge funds and large institutions have $340K invested in Gardiner Healthcare Acquisitions Corp. Unit in 2022 Q4 according to their latest regulatory filings, with funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

63% less funds holding

Funds holding: 83 (-5)

95% less capital invested

Capital invested by funds: $6.27M → $340K (-$5.93M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 5

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
3
Holders Change
-5
Holders Change %
-62.5%
% of All Funds
0.05%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
1
Closed
5
Calls
Puts
Net Calls
Net Calls Change

GDNRU Hedge Fund Activity: Q4 2022 in Review

3 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in Gardiner Healthcare Acquisitions Corp. Unit (GDNRU) for Q4 2022, worth a combined $340K — down 95% from $6.27M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of GDNRU and 0 opened new positions — a net loss of 5 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Yakira Capital Management, cutting an estimated $3.95M.

  • 3 institutional investors held Gardiner Healthcare Acquisitions Corp. Unit (GDNRU) as of Q4 2022, down from 8 in Q3 2022.
  • Funds reported $340K of Gardiner Healthcare Acquisitions Corp. Unit stock for Q4 2022, down 95% quarter-over-quarter.
  • 0 funds opened new Gardiner Healthcare Acquisitions Corp. Unit positions in Q4 2022 and 5 closed out, a net change of -5 holders.
  • The largest Gardiner Healthcare Acquisitions Corp. Unit seller in Q4 2022 was Yakira Capital Management, an estimated $3.95M sold.

Based on aggregated 13F filings for Q4 2022.